Ajanta Pharma Limited (BOM:532331)

India · Delayed Price · Currency is INR

2,910.20

-114.30 (-3.78%)

At close: May 29, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	54.53B	46.48B	42.09B	37.43B	33.41B
Pharmaceuticals Growth	17.31%	10.44%	12.45%	12.02%	15.62%
Total	54.53B	46.48B	42.09B	37.43B	33.41B
Total Growth	17.31%	10.44%	12.45%	12.02%	15.62%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	16.54B	14.52B	13.08B	11.74B	9.82B
India Growth	13.87%	11.07%	11.39%	19.53%	20.82%
Asia Excluding India	11.75B	-	-	-	-
Africa	10.21B	1.47B	2.49B	1.90B	2.06B
Africa Growth	595.93%	-40.99%	30.68%	-7.70%	-24.01%
United States	15.57B	10.47B	9.64B	8.28B	6.96B
United States Growth	48.68%	8.69%	16.40%	18.96%	9.27%
Emerging Market	-	19.41B	16.42B	15.16B	14.00B
Emerging Market Growth	-	18.24%	8.33%	8.25%	24.53%
Total	54.07B	45.88B	41.62B	37.08B	32.84B
Total Growth	17.86%	10.23%	12.25%	12.89%	15.43%

Source: S&P Global Market Intelligence.